Regulatory pressures, AI opportunities draw PE to life sciences software: 8 deals

Ardian, Bregal Sagemount, Riverside and Thoma Bravo are among the PE dealmakers targeting investments in the life sciences software market.

ByJohn R Fischer

11 September 2026•6 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Featured Europe North America UK US Western Europe Healthcare Top Stories

Related articles

alt

Blackstone spots AI and low-cost interceptors opportunity with Falcata defense platform

21 October 2026 · 2 mins read

alt

Exclusive: MSCP bets on aging water infrastructure with The Rapid Group investment

20 October 2026 · 3 mins read

alt

PE eyes cardiometabolic care amid GLP-1 boom, outpatient shifts: 6 deals

16 October 2026 · 3 mins read

alt

Exclusive: Vista agrees to acquire HID's PKI business unit

16 October 2026 · 3 mins read

alt

ArchiMed’s Denis Ribon details €1.5bn fund deployment plans as AI reshapes healthcare

14 October 2026 · 4 mins read

alt

Exclusive: ATL Partners forms Precise Aerospace & Defense platform

13 October 2026 · 3 mins read

alt

Orlando Bravo: BlueMatrix 'will become the standard' for investment research after Aiera add-on

12 October 2026 · 2 mins read

motif